The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?

In a new superseding indictment filed Thursday, prosecutors expanded their sex trafficking and racketeering case against Sean ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Virginia legislators shelve another bill aimed at protecting kids on social media. It's time they stood up to the tech titans ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

THE TV – “Feel tired? Out of energy? Then you need Oxyoxt.” “I used to have broken bones, cancer of the thumbs and nightmares ...

Under the racketeering count, which is now backdated to 2004 from the original indictment’s 2008, prosecutors accuse Combs and his associates of dealing numerous controlled substances, including ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Jan. 13, 2025 — A new study found no changes in opioid outcomes among the general population with the states' passage of medical and recreational marijuana laws. However, the findings also show ...

Rexulti (brexpiprazole) has potential interactions with alcohol and other medications. For example, Rexulti can interact with other antipsychotics, such as risperidone (Risperdal). An interaction ...

Patients and Methods: A randomised, open-label, multicentre, crossover study was conducted in 178 patients requiring treatment for cancer pain, of which 134 were included in the tolerability ...